Key result
Nonsteroidal anti-inflammatory agents remain the first-line treatment for uncomplicated acute pericarditis, which is frequently benign and self-limiting.
Systematic Review
This systematic review highlights that nonsteroidal anti-inflammatory agents remain the first-line treatment for uncomplicated acute pericarditis and emphasizes the role of advanced imaging in managing complications.
Supports NSAID first-line use in uncomplicated cases; confirms guidelines while extending imaging focus for complications.
Pericarditis is a common disorder that has multiple causes and presents in various primary-care and secondary-care settings. It is diagnosed in 0.1% of all hospital admissions and in 5% of emergency room visits for chest pain. Despite the advance of new diagnostic techniques, pericarditis is most commonly idiopathic, and radiation therapy, cardiac surgery, and percutaneous procedures have become important causes. Pericarditis is frequently benign and self-limiting. Nonsteroidal anti-inflammatory agents remain the first-line treatment for uncomplicated cases. Integrated use of new imaging methods facilitates accurate detection and management of complications such as pericardial effusion or constriction. In this article, we perform a systematic review on the etiology, clinical presentation, diagnostic evaluation, and management of acute pericarditis. We summarize current evidence on contemporary and emerging treatment strategies.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2010) conducted a systematic review in Acute pericarditis. Current and emerging treatment strategies was evaluated. Nonsteroidal anti-inflammatory agents remain the first-line treatment for uncomplicated acute pericarditis, which is frequently benign and self-limiting.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: